Pfizer Inc
PFE
ISIN null / Valor 962004
Pfizer Inc
UMushroom community rating:
About company
Pfizer Inc. is a global pharmaceutical corporation that engages in the discovery, development, manufacture, and marketing of a wide range of healthcare products. Its operations span across various segments including innovative health and established health products, focusing on areas such as internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases. Pfizer is known for its commitment to research and development, aiming to address unmet medical needs and improve patient outcomes. The company has made significant strides in the pharmaceutical industry by launching initiatives like an online site for up-to-date information on its U.S. post-marketing commitments, which underscores its dedication to transparency and safety in medicine. Additionally, Pfizer has expanded its reach into animal health through its Agricultural Division, and has ventured into regenerative medicine with the establishment of its Global Regenerative Medicine Unit. The acquisition of Mack Illertissen and the strategic integration of Hospira's portfolio of biosimilars highlight Pfizer's efforts to broaden its product offerings and strengthen its position in the global market. By segmenting its commercial operations into innovative and value business lines, Pfizer aims to cater to both developed and emerging markets, leveraging its scientific expertise and global scale to meet diverse healthcare needs.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
142484 M
Market cap (USD)
96,507,648
Daily traded volume (Shares)
26.58 / 26.24
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Emily Quinapanta
Tariq Howlader
Nojus Okleiteris
EQUITIES OF THE SAME SECTOR
